TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31884563

Group type: EXPERIMENTAL
Intervention: Local farmers surrounding Borena Saynit National Park
Number of subjects: 356

Group type: COMPARATOR
Intervention: Local farmers from unprotected villages
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Both sites (Park boundaries and unprotected site)
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: Respondents from Park boundaries
Number of subjects: 356
Study: 30419032

Group type: EXPERIMENTAL
Intervention: Perceptual tomography method
Number of subjects: 393

Group type: EXPERIMENTAL
Intervention: Balance theory-based partitioning of the perceptual network
Number of subjects: 393
Study: 26618395

Group type: EXPERIMENTAL
Intervention: Textured insoles (worn for 5 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no textured insoles)
Number of subjects: 60
Study: 24774470

Group type: EXPERIMENTAL
Intervention: Tailor‐made weight loss intervention and oral glucosamine sulfate
Number of subjects: 407
Study: 23068560

Group type: EXPERIMENTAL
Intervention: Breath-hold after forced expiration
Number of subjects: 440

Group type: COMPARATOR
Intervention: Control group (no breath-hold maneuver)
Number of subjects: 440
Study: 19926502

Group type: EXPERIMENTAL
Intervention: Prednisone (25 mg daily for 15 days, then 12.5 mg daily for 15 days, then 6.25 mg daily for 15 days, then 6.25 mg on alternate days for 15 days)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg daily for the first month, then on alternate days for the second month)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (100 mg cellulose daily for the first month, then on alternate days for the second month)
Number of subjects: 60
Study: 19061737

Group type: EXPERIMENTAL
Intervention: Low-frequency electric muscle stimulation combined with conventional physical therapy (n=16; 78±8 y)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional physical therapy alone (n=13; 76±10 y)
Number of subjects: 29
Study: 16629642

Group type: EXPERIMENTAL
Intervention: Pegylated interferon alpha‐2b (PEG‐IFN) + lamivudine
Number of subjects: 110

Group type: COMPARATOR
Intervention: Pegylated interferon alpha‐2b (PEG‐IFN)
Number of subjects: 110
Study: 12969085

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg once daily
Number of subjects: 217

Group type: COMPARATOR
Intervention: Esomeprazole 40 mg once daily
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 217
Study: 11016132

Group type: EXPERIMENTAL
Intervention: Two-phase social norm intervention
Number of subjects: 634

Group type: COMPARATOR
Intervention: Standard campus psychoeducational prevention program (Control)
Number of subjects: 634
Study: 8676836

Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus (LBA) treatment
Number of subjects: 8
Study: 1335008

Group type: EXPERIMENTAL
Intervention: Non-invasive daytime ambulatory blood pressure
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Nurse-measured random-zero sphygmomanometer resting blood pressure
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Submaximal exercise systolic blood pressure
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Echocardiographic left ventricular mass
Number of subjects: 28
Study: 4003917

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) aerosol, 4 inhalations twice a day (b.i.d.), total dose 336 micrograms/day for 8 weeks
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo aerosol, 4 inhalations twice a day (b.i.d.) for 8 weeks
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) aerosol, 2 inhalations 4 times a day (q.i.d.), total dose 336 micrograms/day for 2 weeks
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) aerosol, both b.i.d. and q.i.d. regimens
Number of subjects: 89
Study: 31562508

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplement (LNS)
Number of subjects: 5046

Group type: EXPERIMENTAL
Intervention: Cash + LNS
Number of subjects: 5046

Group type: EXPERIMENTAL
Intervention: LNS
Number of subjects: 5046

Group type: COMPARATOR
Intervention: SNACK (control)
Number of subjects: 5046
Study: 28436145

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Tolterodine 4 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 25823620

Group type: EXPERIMENTAL
Intervention: Nutrition intervention (specifics not provided)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention group (nutrition intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy children (control group)
Number of subjects: 0
Study: 24657333

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide users
Number of subjects: 328

Group type: COMPARATOR
Intervention: Nonhydrochlorothiazide participants
Number of subjects: 328
Study: 22456947

Group type: EXPERIMENTAL
Intervention: Bernese periacetabular osteotomy (PAO)
Number of subjects: 26
Study: 20373168

Group type: EXPERIMENTAL
Intervention: Family medicine clerkship with a 3-hour workshop on clinical reasoning using illness scripts.
Number of subjects: 53

Group type: COMPARATOR
Intervention: Psychiatry clerkship (control).
Number of subjects: 53
Study: 18632187

Group type: EXPERIMENTAL
Intervention: Abdominal compression
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Valsalva maneuver
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Reverse Trendelenburg's position with abdominal compression
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Valsalva maneuver in reverse Trendelenburg's position
Number of subjects: 50
Study: 19450096

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 1327

Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 1327
Study: 15034161

Group type: EXPERIMENTAL
Intervention: Ketoconazole 100 mg/day in addition to tacrolimus
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no ketoconazole)
Number of subjects: 70
Study: 11282779

Group type: EXPERIMENTAL
Intervention: Deep Inspiration (DI)
Number of subjects: 19
Study: 9389427

Group type: EXPERIMENTAL
Intervention: Structured NIDDM care with diabetes service support (SG)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Standard care without diabetes service support (CG)
Number of subjects: 350
Study: 7614594

Group type: EXPERIMENTAL
Intervention: dietetic therapy of chinese herb rhizome wheat starch
Number of subjects: 30

Group type: COMPARATOR
Intervention: control group
Number of subjects: 30
Study: 3277325

Group type: EXPERIMENTAL
Intervention: Definitive radiation therapy with additional cyclophosphamide (Cytoxan) or estramustine phosphate (Emcyt) chemotherapy for 2 years
Number of subjects: 254

Group type: COMPARATOR
Intervention: Definitive radiation therapy only
Number of subjects: 254
Study: 31269203

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 48

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 48
Study: 28008609

Group type: EXPERIMENTAL
Intervention: FITT-C (n = 133)
Number of subjects: 250

Group type: COMPARATOR
Intervention: TS (n = 117)
Number of subjects: 250
Study: 27671243

Group type: EXPERIMENTAL
Intervention: Progressive treadmill walking exercise training for 12 weeks
Number of subjects: 10
Study: 25257905

Group type: EXPERIMENTAL
Intervention: Autogenous bone cement (ABC)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Autogenous bone dust (ABD)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Blank control (BC)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Operation control (OC)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Ototoxicity positive control (OPC)
Number of subjects: 53
Study: 22899947

Group type: EXPERIMENTAL
Intervention: Transamidated gluten (3.7 g/day)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Nontransamidated gluten (control group)
Number of subjects: 47
Study: 19865058

Group type: EXPERIMENTAL
Intervention: EPO (subcutaneous 2000 microg three times weekly) plus parenteral iron
Number of subjects: 40

Group type: COMPARATOR
Intervention: Parenteral iron only
Number of subjects: 40
Study: 17711378

Group type: EXPERIMENTAL
Intervention: Enfuvirtide plus optimized background (ENF plus OB)
Number of subjects: 997

Group type: COMPARATOR
Intervention: Optimized background (OB) only
Number of subjects: 997
Study: 15746730

Group type: EXPERIMENTAL
Intervention: Endoscopic vein harvest
Number of subjects: 200

Group type: COMPARATOR
Intervention: Open vein harvest
Number of subjects: 200
Study: 12195238

Group type: EXPERIMENTAL
Intervention: IL‐2 plus MLT
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: IL‐2 plus MLT plus NTX
Number of subjects: 14
Study: 9529266

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens therapy at 0.625 mg daily
Number of subjects: 366
Study: 7872882

Group type: EXPERIMENTAL
Intervention: Divalproex
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 2388978

Group type: EXPERIMENTAL
Intervention: Dextrose tablets
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sorbitol tablets (control)
Number of subjects: 20
Study: 832943

Group type: EXPERIMENTAL
Intervention: Undecylenic acid powder preparations
Number of subjects: 104

Group type: COMPARATOR
Intervention: Talc vehicle or left untreated
Number of subjects: 104
Study: 31820289

Group type: EXPERIMENTAL
Intervention: Ibudilast (IBUD) 50 mg twice daily for 12 weeks
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Ibudilast (IBUD)
Number of subjects: 125
Study: 31120501

Group type: EXPERIMENTAL
Intervention: GA plus HCQ
Number of subjects: 112

Group type: COMPARATOR
Intervention: GA
Number of subjects: 112
Study: 28658112

Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg propofol (LPE group)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: 0.50 mg/kg propofol (MPE group)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: 0.75 mg/kg propofol (HPE group)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: 1 to 2 mg/kg propofol (P group)
Number of subjects: 363

Group type: COMPARATOR
Intervention: 0 mg/kg propofol (E group)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: P group
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: HPE group and P group
Number of subjects: 363
Study: 25761129

Group type: EXPERIMENTAL
Intervention: rhFSH 300 IU for 5 months
Number of subjects: 354

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: rhFSH (200 IU and above)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: rhFSH
Number of subjects: 354
Study: 23958526

Group type: EXPERIMENTAL
Intervention: No-touch technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 40
Study: 21368386

Group type: EXPERIMENTAL
Intervention: Folic acid 2 mg/d
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Folic acid 5 mg/d
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Folic acid 10 mg/d
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Folic acid 15 mg/d
Number of subjects: 31
Study: 19267739

Group type: EXPERIMENTAL
Intervention: Chemotherapy at a community hospital
Number of subjects: 42

Group type: COMPARATOR
Intervention: Chemotherapy at a cancer centre
Number of subjects: 42
Study: 16900105

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD) with long allele homozygotes
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Long allele homozygotes
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Short allele carriers
Number of subjects: 35
Study: 15482444

Group type: EXPERIMENTAL
Intervention: Direct instructions for retrieval of original responses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indirect instructions allowing automatic responses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 0
Study: 11339776

Group type: EXPERIMENTAL
Intervention: Sevoflurane continued
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sevoflurane stopped
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Isoflurane continued
Number of subjects: 120

Group type: COMPARATOR
Intervention: Isoflurane stopped
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Propofol continued
Number of subjects: 120

Group type: COMPARATOR
Intervention: Propofol stopped
Number of subjects: 120
Study: 9692452

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid drainage combined with intrathecal papaverine (CSFDr + IP)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no CSFDr + IP)
Number of subjects: 33
Study: 8156465

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy with acetylsalicylic acid
Number of subjects: 436

Group type: COMPARATOR
Intervention: Medical management (nonoperative)
Number of subjects: 436
Study: 3345643

Group type: EXPERIMENTAL
Intervention: Sucralfate (1-g tablet, four times a day for two days before and after theophylline dose)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Non-sustained-release theophylline (5-mg/kg dose)
Number of subjects: 8
Study: 31688528

Group type: EXPERIMENTAL
Intervention: Fast track catheter removal (day of surgery, 4 hours after surgery)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Conventional catheter removal (postoperative day 1)
Number of subjects: 164
Study: 31227600

Group type: EXPERIMENTAL
Intervention: Analysis of protein abundance and phosphopeptide abundance
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Individual kinases
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Motif-based analysis
Number of subjects: 150
Study: 27912982

Group type: EXPERIMENTAL
Intervention: Budesonide 400 μg (200 μg for those aged <11 years)
Number of subjects: 7138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7138
Study: 25966723

Group type: EXPERIMENTAL
Intervention: SRP plus azithromycin (AZT group)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: SRP plus metronidazole and amoxicillin (M+A group)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Scaling and root planning (SRP) only
Number of subjects: 45
Study: 23149171

Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency defined as 25(OH)D level <20 ng/mL
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 25(OH)D levels measured at baseline, cessation of cardiopulmonary bypass, and 24 hours postoperatively
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Postoperative 25(OH)D levels
Number of subjects: 70
Study: 21785293

Group type: EXPERIMENTAL
Intervention: Decreasing distance sprint interval training
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Increasing distance sprint interval training
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both types of sprint interval training
Number of subjects: 12
Study: 19337684

Group type: EXPERIMENTAL
Intervention: RCTs with financial funding
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: RCTs with sample size >78 patients
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Overall RCTs
Number of subjects: 159
Study: 16936184

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 352

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 352
Study: 15201620

Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy with LDL-c level < 100 mg/dl
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy with LDL-c level > 100 mg/dl
Number of subjects: 99
Study: 11726481

Group type: EXPERIMENTAL
Intervention: Continuous endurance exercise training programme (CT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intermittent endurance exercise training programme (IT)
Number of subjects: 12
Study: 9515854

Group type: EXPERIMENTAL
Intervention: Extended-use hygroscopic condenser humidifier
Number of subjects: 310

Group type: COMPARATOR
Intervention: Heated-water humidification
Number of subjects: 310
Study: 8042971

Group type: EXPERIMENTAL
Intervention: Treatment (comprehensive relapse prevention program)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 155
Study: 3076905

Group type: EXPERIMENTAL
Intervention: Amitriptyline (median dose 125 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30807589

Group type: EXPERIMENTAL
Intervention: mF75 (isocaloric modified F75 without lactose and with reduced carbohydrate)
Number of subjects: 843

Group type: COMPARATOR
Intervention: F75 (standard formula)
Number of subjects: 843

Group type: EXPERIMENTAL
Intervention: mF75
Number of subjects: 843

Group type: COMPARATOR
Intervention: F75
Number of subjects: 843
Study: 28715944

Group type: EXPERIMENTAL
Intervention: Low abrasive air polishing powder (Air‐Flow® Perio, EMS) (AFP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Titanium curettes (TC)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 20
Study: 26009206

Group type: EXPERIMENTAL
Intervention: Dissociation from a beloved candy brand
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dissociation from beloved brands (implicit and explicit methods)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dissociation from beloved brands
Number of subjects: 0
Study: 23013513

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Ezetimibe 10 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Combination of simvastatin and ezetimibe
Number of subjects: 72
Study: 21732834

Group type: EXPERIMENTAL
Intervention: Isoniazid (10 to 20 mg per kilogram of body weight per day)
Number of subjects: 1352

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1352

Group type: EXPERIMENTAL
Intervention: Isoniazid
Number of subjects: 1352
Study: 19380337

Group type: EXPERIMENTAL
Intervention: Mediwrap blanket
Number of subjects: 30

Group type: COMPARATOR
Intervention: Forced air warming (FAW) blanket
Number of subjects: 30
Study: 16402128

Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine spray
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline smoking behaviour
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3-hydroxycotinine/cotinine ratio
Number of subjects: 0
Study: 15296689

Group type: EXPERIMENTAL
Intervention: Postcard reminder and follow-up visit by a promotora
Number of subjects: 0

Group type: COMPARATOR
Intervention: Postcard reminder only
Number of subjects: 0
Study: 12483417

Group type: EXPERIMENTAL
Intervention: Conventional two‐compartment model
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Two‐compartment model accounting for RV spillover
Number of subjects: 75
Study: 11075741

Group type: EXPERIMENTAL
Intervention: Cerivastatin 0.3 mg
Number of subjects: 1030

Group type: EXPERIMENTAL
Intervention: Cerivastatin 0.4 mg
Number of subjects: 1030

Group type: COMPARATOR
Intervention: Cerivastatin and pravastatin
Number of subjects: 1030
Study: 8610903

Group type: EXPERIMENTAL
Intervention: Sevoflurane (1.7% at 1 MAC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Isoflurane (1.2% at 1 MAC)
Number of subjects: 20
Study: 1578625

Group type: EXPERIMENTAL
Intervention: Bair Hugger (BH)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Warming Blanket (WB)
Number of subjects: 16
Study: 3932685

Group type: EXPERIMENTAL
Intervention: Thiotepa
Number of subjects: 83

Group type: COMPARATOR
Intervention: Mitomycin C
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Thiotepa (crossover)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Mitomycin C (crossover)
Number of subjects: 83
Study: 3453428

Group type: EXPERIMENTAL
Intervention: 10 mg haloperidol/day for 14 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 20 mg haloperidol/day for 14 days
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Individually adapted haloperidol dose for 14 days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standardized treatment (10 mg or 20 mg haloperidol)
Number of subjects: 48
Study: 31605794

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (100 to 200 mg every 3 weeks for up to 16 cycles)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Thoracic radiotherapy (TRT)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Combined pembrolizumab and TRT
Number of subjects: 38
Study: 31397298

Group type: EXPERIMENTAL
Intervention: Self-reported weight
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Self-reported BMI
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Self-reported height
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Measured BMI
Number of subjects: 159
Study: 28715535

Group type: EXPERIMENTAL
Intervention: Transforming Opioid Prescribing in Primary Care (TOPCARE) intervention including nurse care management, electronic registry, 1-on-1 academic detailing, and electronic decision tools for safe opioid prescribing
Number of subjects: 985

Group type: EXPERIMENTAL
Intervention: TOPCARE intervention
Number of subjects: 985

Group type: COMPARATOR
Intervention: Control group received electronic decision tools only
Number of subjects: 985
Study: 26062091

Group type: EXPERIMENTAL
Intervention: Conventional drop of fluorescein solution (20 mg/mL) administered to the right eye
Number of subjects: 18

Group type: COMPARATOR
Intervention: Ocular mist (10 μL) of fluorescein solution (20 mg/mL) applied to the left eye
Number of subjects: 18
Study: 23428214

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 198
Study: 21654252

Group type: EXPERIMENTAL
Intervention: Standard clinical protocol (sustained submaximal anal and pelvic floor exercises)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Alternative group (rapid squeeze plus sustained submaximal exercises)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Overall exercise compliance
Number of subjects: 72
Study: 19699858

Group type: EXPERIMENTAL
Intervention: Remote surveillance technology with continuous ambulatory monitoring of the atrial electrogram for anticoagulation management.
Number of subjects: 227

Group type: COMPARATOR
Intervention: Conventional clinical management for anticoagulation decision-making.
Number of subjects: 227
Study: 16722841

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Diphenhydramine 75 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15